Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
PPAR2265 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A10904 | 31132306 | Scand J Immunol | Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice. | 2019 | Details |
A10934 | 31114547 | Front Endocrinol (Lausanne) | Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients. | 2019 | Details |
A10943 | 31111657 | Obes Rev | The effects of oleoylethanolamide, an endogenous PPAR-α agonist, on risk factors for NAFLD: A systematic review. | 2019 | Details |
A10979 | 31094171 | Ter Arkh | Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis. | 2019 | Details |
A10985 | 31090336 | Zhongguo Zhong Yao Za Zhi | [Analysis on mechanisms and medication rules of herbal prescriptions for nonalcoholic fatty liver disease based on methods of data mining and biological information]. | 2019 | Details |
A11053 | 31064820 | Biosci Rep | LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease. | 2019 | Details |
A11056 | 31064103 | Nutrients | Fermented Cordyceps militaris Extract Prevents Hepatosteatosis and Adipocyte Hypertrophy in High Fat Diet-Fed Mice. | 2019 | Details |
A11059 | 31063640 | Hepatology | Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast-Food Diet Model. | 2019 | Details |
A11110 | 31037218 | J Nutr Sci | Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis. | 2019 | Details |
A11124 | 31032705 | Autophagy | Lysosomal inhibition attenuates peroxisomal gene transcription via suppression of PPARA and PPARGC1A levels. | 2019 | Details |
A11132 | 31028903 | Pharmacol Res | Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH. | 2019 | Details |
A11136 | 31026873 | Planta Med | Preventive Effects of Total Flavonoid C-Glycosides from Abrus mollis on Nonalcoholic Fatty Liver Disease through Activating the PPARα Signaling Pathway. | 2019 | Details |
A11154 | 31020720 | Exp Physiol | Combined treatment of dipeptidyl peptidase-4 inhibitor and exercise training improves lipid profile in KK/Ta mice. | 2019 | Details |
A11221 | 30987865 | Clin Investig Arterioscler | Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes. | 2019 | Details |
A11223 | 30987167 | Int J Mol Sci | Ameliorative Effect of Spinach on Non-Alcoholic Fatty Liver Disease Induced in Rats by a High-Fat Diet. | 2019 | Details |
A11231 | 30983568 | Elife | Dynamic repression by BCL6 controls the genome-wide liver response to fasting and steatosis. | 2019 | Details |
A11238 | 30978698 | J Mol Endocrinol | Humulus japonicus stimulates thermogenesis and ameliorates oxidative stress in mouse adipocytes. | 2019 | Details |
A11245 | 30975991 | Nat Commun | Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα. | 2019 | Details |
A11246 | 30975380 | Prostaglandins Leukot Essent Fatty Acids | Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPARγ signaling. | 2019 | Details |
A11276 | 30962743 | Yonago Acta Med | Gene Expression Analysis of the Activating Factor 3/Nuclear Protein 1 Axis in a Non-alcoholic Steatohepatitis Mouse Model. | 2019 | Details |
A11279 | 30961499 | Curr Vasc Pharmacol | Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. | 2020 | Details |
A11286 | 30957185 | Mol Med Rep | Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells. | 2019 | Details |
A11297 | 30950217 | J Cell Mol Med | Aucubin inhibited lipid accumulation and oxidative stress via Nrf2/HO-1 and AMPK signalling pathways. | 2019 | Details |
A11307 | 30945694 | J Genet | Genetics of nonalcoholic fatty liver disease in Asian populations. | 2019 | Details |
A11321 | 30939745 | Int J Mol Sci | 2, 3, 4', 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms. | 2019 | Details |
A11323 | 30937936 | J Cell Physiol | Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes. | 2019 | Details |
A11359 | 30923554 | Cell Mol Biol Lett | The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus. | 2019 | Details |
A11413 | 30905315 | Adipocyte | Adipocytes as lipid sensors of oleic acid transport through a functional Caco-2/HT29-MTX intestinal barrier. | 2019 | Details |
A11440 | 30894137 | BMC Gastroenterol | The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience. | 2019 | Details |
A11477 | 30879920 | EBioMedicine | Arid1a regulates insulin sensitivity and lipid metabolism. | 2019 | Details |
A11480 | 30878016 | J Endocrinol | Short-term strength training reduces gluconeogenesis and NAFLD in obese mice. | 2019 | Details |
A11497 | 30871035 | Nutrients | Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. | 2019 | Details |
A11528 | 30856468 | J Nutr Biochem | Tissue-dependent effects of cis-9,trans-11- and trans-10,cis-12-CLA isomers on glucose and lipid metabolism in adult male mice. | 2019 | Details |
A11539 | 30851372 | J Ethnopharmacol | Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways. | 2019 | Details |
A11542 | 30850637 | Sci Rep | Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan. | 2019 | Details |
A11551 | 30847736 | Curr Obes Rep | Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery. | 2019 | Details |
A11557 | 30841472 | Biomed Pharmacother | Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue. | 2019 | Details |
A11580 | 30832407 | Nutrients | Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function. | 2019 | Details |
A11624 | 30814493 | Cell Death Dis | PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation. | 2019 | Details |
A11625 | 30813654 | Nutrients | Lonicera caerulea Extract Attenuates Non-Alcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Hepatocytes and in High Fat Diet-Fed Mice. | 2019 | Details |
A11626 | 30813440 | Nutrients | Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial. | 2019 | Details |
A11645 | 30807179 | J Proteome Res | Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis. | 2019 | Details |
A11666 | 30797009 | Int J Biol Macromol | Mussel polysaccharide α-D-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways. | 2019 | Details |
A11675 | 30793973 | Genet Test Mol Biomarkers | Interaction Between AGTR1 and PPARγ Gene Polymorphisms on the Risk of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A11679 | 30792450 | Sci Rep | Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1. | 2019 | Details |
A11680 | 30792163 | Arch Med Res | Therapeutic Intranasal Vaccine HB-ATV-8 Prevents Atherogenesis and Non-alcoholic Fatty Liver Disease in a Pig Model of Atherosclerosis. | 2019 | Details |
A11693 | 30789804 | Int J Vitam Nutr Res | Liver Histological Improvement After Administration of High-Dose Vitamin C in Guinea Pig with Nonalcoholic Steatohepatitis. | 2019 | Details |
A11724 | 30776032 | Food Funct | Myricetin alleviated hepatic steatosis by acting on microRNA-146b/thyroid hormone receptor b pathway in high-fat diet fed C57BL/6J mice. | 2019 | Details |
A11739 | 30770098 | Biochem Biophys Res Commun | Genetic deletion of β2 adrenergic receptors exacerbates hepatocellular lipid accumulation in high-fat diet mice. | 2019 | Details |
A11766 | 32598624 | Ter Arkh | [Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis]. | 2019 | Details |
A11778 | 30748020 | Hepatology | Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor γ in Mice. | 2019 | Details |
A11786 | 30745416 | J Pharmacol Exp Ther | RLA8-A New and Highly Effective Quadruple PPAR-α/γ/δ and GPR40 Agonist to Reverse Nonalcoholic Steatohepatitis and Fibrosis. | 2019 | Details |
A11796 | 30737662 | Inflammation | Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis. | 2019 | Details |
A11806 | 30732555 | Eur J Sport Sci | Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. | 2019 | Details |
A11826 | 30719457 | J Immunol Res | The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD. | 2019 | Details |
A11836 | 30713255 | Biol Pharm Bull | Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice. | 2019 | Details |
A11839 | 30711707 | Toxicology | The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice. | 2019 | Details |
A11843 | 30711017 | Lipids Health Dis | Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. | 2019 | Details |
A11900 | 30689650 | PLoS One | Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice. | 2019 | Details |
A11926 | 30680004 | Exp Ther Med | Gemfibrozil reduces lipid accumulation in SMMC-7721 cells via the involvement of PPARα and SREBP1. | 2018 | Details |
A11932 | 30675881 | Food Funct | Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway. | 2019 | Details |
A11967 | 30664220 | Int J Mol Med | SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway. | 2019 | Details |
A11973 | 30660906 | Chemosphere | Long-term bisphenol S exposure induces fat accumulation in liver of adult male zebrafish (Danio rerio) and slows yolk lipid consumption in F1 offspring. | 2019 | Details |
A11978 | 30659956 | Exp Gerontol | Osthole inhibits oleic acid/lipopolysaccharide-induced lipid accumulation and inflammatory response through activating PPARα signaling pathway in cultured hepatocytes. | 2019 | Details |
A11985 | 30658440 | Int J Mol Sci | Interactions between Host PPARs and Gut Microbiota in Health and Disease. | 2019 | Details |
A12054 | 30621686 | Lipids Health Dis | Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. | 2019 | Details |
A12071 | 30615941 | Metab Eng | Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function. | 2019 | Details |
A12076 | 30611993 | Biomed Pharmacother | Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. | 2019 | Details |
A12077 | 30611723 | Toxicol Appl Pharmacol | Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells. | 2019 | Details |
A12078 | 30611703 | Alcohol | Effect of nanoformulated copper/zinc superoxide dismutase on chronic ethanol-induced alterations in liver and adipose tissue. | 2019 | Details |
A12080 | 30611282 | Lipids Health Dis | Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet. | 2019 | Details |
A12131 | 30590197 | J Ethnopharmacol | Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha. | 2018 | Details |
A12137 | 30588181 | Int J Med Sci | Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
A12152 | 30580553 | Crit Rev Food Sci Nutr | n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. | 2018 | Details |
A12155 | 30579258 | Biomed Pharmacother | Administration of methyl palmitate prevents non-alcoholic steatohepatitis (NASH) by induction of PPAR-α. | 2018 | Details |
A12177 | 30573812 | Acta Pharmacol Sin | A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters. | 2018 | Details |
A12182 | 30572788 | Biosci Biotechnol Biochem | A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors. | 2018 | Details |
A12192 | 30568000 | Biochem J | ZNF300 stimulates fatty acid oxidation and alleviates hepatosteatosis through regulating PPARα. | 2019 | Details |
A12195 | 30567368 | Int J Mol Sci | Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil. | 2018 | Details |
A12198 | 30566427 | PLoS Biol | Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis. | 2018 | Details |
A12206 | 30562559 | Biochim Biophys Acta Mol Basis Dis | Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice. | 2018 | Details |
A12209 | 30561132 | Basic Clin Pharmacol Toxicol | A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease. | 2019 | Details |
A12218 | 30558790 | Biochem Biophys Res Commun | Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease. | 2018 | Details |
A12223 | 30556145 | Hepatology | Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A12228 | 30555521 | Nutr Metab (Lond) | Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice. | 2018 | Details |
A12240 | 30551380 | Biomed Pharmacother | Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism. | 2018 | Details |
A12249 | 30547786 | BMC Med Genomics | Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. | 2018 | Details |
A12295 | 30522014 | Biomed Pharmacother | Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development. | 2018 | Details |
A12302 | 30518830 | Nat Rev Gastroenterol Hepatol | Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators. | 2019 | Details |
A12310 | 30504232 | J Lipid Res | Hepatic transcriptome analysis from HFD-fed mice defines a long noncoding RNA regulating cellular cholesterol levels. | 2018 | Details |
A12321 | 30516003 | Physiol Rep | Exercise training suppresses scavenger receptor CD36 expression in kupffer cells of nonalcoholic steatohepatitis model mice. | 2018 | Details |
A12334 | 30510994 | Cell Mol Gastroenterol Hepatol | Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice. | 2018 | Details |
A12374 | 30482436 | J Pharmacol Sci | Lipid-modulate activity of Cichorium glandulosum Boiss. et Huet polysaccharide in nonalcoholic fatty liver disease larval zebrafish model. | 2018 | Details |
A12389 | 30473364 | Lancet | Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK. | 2018 | Details |
A12390 | 30473057 | Metabolism | Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models. | 2018 | Details |
A12392 | 30472977 | J Pharm Pharm Sci | Non-alcoholic Steatohepatitis (NASH) Drug Discovery - Building a Consensus on ADME Screening Tools and Clinical Pharmacology Strategies to Aid Candidate Development. | 2018 | Details |
A12433 | 30457067 | Proc Nutr Soc | Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state. | 2018 | Details |
A12450 | 30451987 | Eur J Clin Nutr | Diet with greater inflammatory potential is associated with higher prevalence of fatty liver among US adults. | 2018 | Details |
A12486 | 30428868 | Lipids Health Dis | Changes in peroxisome proliferator-activated receptor alpha target gene expression in peripheral blood mononuclear cells associated with non-alcoholic fatty liver disease. | 2018 | Details |
A12513 | 30413815 | Lab Invest | Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero. | 2018 | Details |